This company is no longer activeThe company may no longer be operating, as it may be out of business. Find out why through their latest events.See Latest EventsSteep Hill (CD0) 주식 개요는 큰 규모의 사업을 운영하고 있지 않습니다. 자세히 보기CD0 펀더멘털 분석스노우플레이크 점수가치 평가2/6미래 성장0/6과거 실적0/6재무 건전성6/6배당0/6위험 분석주식은 유동성이 매우 낮습니다수익이 USD$1m 미만입니다(CA$0)의미 있는 시가총액이 없습니다(€551K)모든 위험 점검 보기CD0 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€0.029해당 없음내재 할인율Est. Revenue$PastFuture-4m1m2016201920222025202620282031Revenue CA$0.3Earnings CA$0.05AdvancedSet Fair ValueView all narrativesSteep Hill Inc. 경쟁사EpigenomicsSymbol: DB:ECXMarket cap: €763.0kBiofronteraSymbol: XTRA:B8FKMarket cap: €14.7mbioXXmedSymbol: XTRA:T5O0Market cap: €329.8kCaptor CapitalSymbol: CNSX:CPTRMarket cap: CA$767.1k가격 이력 및 성과Steep Hill 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가CA$0.02952주 최고가CA$0.03952주 최저가CA$0.012베타1.871개월 변동0%3개월 변동-12.12%1년 변동-14.71%3년 변동286.72%5년 변동n/aIPO 이후 변동-86.67%최근 뉴스 및 업데이트공시 • May 16Good Purpose Investments Inc. completed the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction.Good Purpose Investments Inc. entered into an agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 1.8 million in a reverse merger transaction on November 12, 2025. Good Purpose shareholders will exchange all of the common shares of Good Purpose for post-Consolidation common shares of the Resulting Issuer based on an exchange ratio equal to one Resulting Issuer Shares for each one Good Purpose Share to a maximum of 62 million Resulting Issuer Shares. As of December 19, 2025, the parties entered into an amending agreement such that Good Purpose shareholders will exchange all of the common shares of Good Purpose for post-consolidation common shares of the Resulting Issuer, based on an exchange ratio equal to one Resulting Issuer Shares for each one Good Purpose Share to a maximum of 30,818,614 Resulting Issuer Shares. As such, the Transaction will result in a reverse takeover of the Steep Hill by the shareholders of Good Purpose upon completion of the Transaction, and the Resulting Issuer’s primary business will be the business of Good Purpose. In connection with the Transaction, the Steep Hill intends to: (i) change its name to “Good Purpose Investments Inc.” or such other name as the Steep Hill and Good Purpose may mutually agree; (ii) change its stock exchange ticker symbol to a symbol to be determined between the parties and acceptable to the CSE; (iii) consolidate its issued and outstanding common shares on the basis of one post consolidation common shares for every three pre-consolidation common shares of the Steep Hill; and (iv) reconstitute its board of directors and management team. Completion of the Transaction is subject to a number of terms and conditions customary for transactions of this nature, including, among other things, Good Purpose having completed the Good Purpose Financing receipt of all necessary shareholder and regulatory approvals contemplated in the Amalgamation Agreement, the execution of related transaction documents, and listing approval of the CSE. In addition, the Transaction must be approved by not less than 66% of the votes cast at a meeting of shareholders of Good Purpose. The Company will also seek approval of the Transaction, the Name Change and the Consolidation at a meeting of the Steep Hill's shareholders. Certain securities issued in connection with the Transaction will be subject to escrow requirements of the CSE, mutually agreed upon escrow conditions, and hold periods as required by the CSE and applicable securities laws. Steep Hill Inc. board recommend the transaction. The special meeting of shareholders of Steep Hill will be held to approve the transaction on March 26, 2026. As of March 26, 2026, the parties extended the outside date for completion of the transaction to May 7, 2026. Endeavor Trust Corporation acted as transfer agent for Steep Hill Inc. Good Purpose Investments Inc. completed the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction on May 14, 2026. Upon completion of the Transaction, 7.36% of the Common Shares being held by shareholders of Steep Hill Inc. and 92.64% of the Common Shares being held by GPI shareholders. Steep Hill Inc. changed its name to Good Purpose Investments Inc. The Common Shares are expected to commence trading on the CSE under the new name and the new ticker symbol “GPIN” as of market open on May 19, 2026. Concurrently with Closing, the board of directors of Steep Hill Inc. was reconstituted to consist of Monique Maissan, Max Whiffin, Hani Zabaneh and Sameet Kanade. George Tsogas has been appointed Chief Executive Officer, Melissa Kinnoch has been appointed Chief Financial Officer and Corporate Secretary, Monique Maissan has been appointed Chief Development Officer and Max Whiffin has been appointed Vice President, Corporate Development.공시 • Nov 14Good Purpose Investments Inc. entered into an agreement to acquire Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction.Good Purpose Investments Inc. entered into an agreement to acquire Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction on November 12, 2025. Good Purpose shareholders will exchange all of the common shares of Good Purpose for post-Consolidation common shares of the Resulting Issuer based on an exchange ratio equal to one Resulting Issuer Shares for each one Good Purpose Share to a maximum of 62 million Resulting Issuer Shares. As such, the Transaction will result in a reverse takeover of the Steep Hill by the shareholders of Good Purpose upon completion of the Transaction, and the Resulting Issuer’s primary business will be the business of Good Purpose. In connection with the Transaction, the Steep Hill intends to: (i) change its name to “Good Purpose Investments Inc.” or such other name as the Steep Hill and Good Purpose may mutually agree; (ii) change its stock exchange ticker symbol to a symbol to be determined between the parties and acceptable to the CSE; (iii) consolidate its issued and outstanding common shares on the basis of one post consolidation common shares for every three pre-consolidation common shares of the Steep Hill; and (iv) reconstitute its board of directors and management team. Completion of the Transaction is subject to a number of terms and conditions customary for transactions of this nature, including, among other things, Good Purpose having completed the Good Purpose Financing receipt of all necessary shareholder and regulatory approvals contemplated in the Amalgamation Agreement, the execution of related transaction documents, and listing approval of the CSE. In addition, the Transaction must be approved by not less than 66?% of the votes cast at a meeting of shareholders of Good Purpose. The Company will also seek approval of the Transaction, the Name Change and the Consolidation at a meeting of the Steep Hill's shareholders. Certain securities issued in connection with the Transaction will be subject to escrow requirements of the CSE, mutually agreed upon escrow conditions, and hold periods as required by the CSE and applicable securities laws.공시 • Jul 04Lir Life Sciences Inc. cancelled the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction.Lir Life Sciences Inc. entered into a share purchase agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 8.2 million in a reverse merger transaction on February 12, 2025. As part of the consideration, 136,054,422 common shares of Steep Hill issued at the price of CAD 0.147. Lir will be required to complete an equity financing for proceeds of at least CAD 1,000,000 concurrently with the closing of the Acquisition, and the Company’s shares will be consolidated on a 3-for-1 basis immediately following completion of the Acquisition and Concurrent Financing. Concurrently with the completion of the Acquisition, all current Directors of the Company, except for Mr. Sameet Kanade, will resign and be replaced by nominees of LIR. The transaction is subject to the approval of target's shareholders, regulatory approvals and the consummation of concurrent financing. Lir Life Sciences Inc. cancelled the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction on July 3, 2025.공시 • Apr 02Steep Hill Inc., Annual General Meeting, May 15, 2025Steep Hill Inc., Annual General Meeting, May 15, 2025.공시 • Mar 05Steep Hill Inc., Annual General Meeting, Apr 07, 2025Steep Hill Inc., Annual General Meeting, Apr 07, 2025.공시 • Feb 14Lir Life Sciences Inc. entered into a share purchase agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 8.2 million in a reverse merger transaction.Lir Life Sciences Inc. entered into a share purchase agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 8.2 million in a reverse merger transaction on February 12, 2025. As part of the consideration, 136,054,422 common shares of Steep Hill issued at the price of CAD 0.147. Lir will be required to complete an equity financing for proceeds of at least CAD 1,000,000 concurrently with the closing of the Acquisition, and the Company’s shares will be consolidated on a 3-for-1 basis immediately following completion of the Acquisition and Concurrent Financing. Concurrently with the completion of the Acquisition, all current Directors of the Company, except for Mr. Sameet Kanade, will resign and be replaced by nominees of LIR. The transaction is subject to the approval of target's shareholders, regulatory approvals and the consummation of concurrent financing.더 많은 업데이트 보기Recent updates공시 • May 16Good Purpose Investments Inc. completed the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction.Good Purpose Investments Inc. entered into an agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 1.8 million in a reverse merger transaction on November 12, 2025. Good Purpose shareholders will exchange all of the common shares of Good Purpose for post-Consolidation common shares of the Resulting Issuer based on an exchange ratio equal to one Resulting Issuer Shares for each one Good Purpose Share to a maximum of 62 million Resulting Issuer Shares. As of December 19, 2025, the parties entered into an amending agreement such that Good Purpose shareholders will exchange all of the common shares of Good Purpose for post-consolidation common shares of the Resulting Issuer, based on an exchange ratio equal to one Resulting Issuer Shares for each one Good Purpose Share to a maximum of 30,818,614 Resulting Issuer Shares. As such, the Transaction will result in a reverse takeover of the Steep Hill by the shareholders of Good Purpose upon completion of the Transaction, and the Resulting Issuer’s primary business will be the business of Good Purpose. In connection with the Transaction, the Steep Hill intends to: (i) change its name to “Good Purpose Investments Inc.” or such other name as the Steep Hill and Good Purpose may mutually agree; (ii) change its stock exchange ticker symbol to a symbol to be determined between the parties and acceptable to the CSE; (iii) consolidate its issued and outstanding common shares on the basis of one post consolidation common shares for every three pre-consolidation common shares of the Steep Hill; and (iv) reconstitute its board of directors and management team. Completion of the Transaction is subject to a number of terms and conditions customary for transactions of this nature, including, among other things, Good Purpose having completed the Good Purpose Financing receipt of all necessary shareholder and regulatory approvals contemplated in the Amalgamation Agreement, the execution of related transaction documents, and listing approval of the CSE. In addition, the Transaction must be approved by not less than 66% of the votes cast at a meeting of shareholders of Good Purpose. The Company will also seek approval of the Transaction, the Name Change and the Consolidation at a meeting of the Steep Hill's shareholders. Certain securities issued in connection with the Transaction will be subject to escrow requirements of the CSE, mutually agreed upon escrow conditions, and hold periods as required by the CSE and applicable securities laws. Steep Hill Inc. board recommend the transaction. The special meeting of shareholders of Steep Hill will be held to approve the transaction on March 26, 2026. As of March 26, 2026, the parties extended the outside date for completion of the transaction to May 7, 2026. Endeavor Trust Corporation acted as transfer agent for Steep Hill Inc. Good Purpose Investments Inc. completed the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction on May 14, 2026. Upon completion of the Transaction, 7.36% of the Common Shares being held by shareholders of Steep Hill Inc. and 92.64% of the Common Shares being held by GPI shareholders. Steep Hill Inc. changed its name to Good Purpose Investments Inc. The Common Shares are expected to commence trading on the CSE under the new name and the new ticker symbol “GPIN” as of market open on May 19, 2026. Concurrently with Closing, the board of directors of Steep Hill Inc. was reconstituted to consist of Monique Maissan, Max Whiffin, Hani Zabaneh and Sameet Kanade. George Tsogas has been appointed Chief Executive Officer, Melissa Kinnoch has been appointed Chief Financial Officer and Corporate Secretary, Monique Maissan has been appointed Chief Development Officer and Max Whiffin has been appointed Vice President, Corporate Development.공시 • Nov 14Good Purpose Investments Inc. entered into an agreement to acquire Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction.Good Purpose Investments Inc. entered into an agreement to acquire Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction on November 12, 2025. Good Purpose shareholders will exchange all of the common shares of Good Purpose for post-Consolidation common shares of the Resulting Issuer based on an exchange ratio equal to one Resulting Issuer Shares for each one Good Purpose Share to a maximum of 62 million Resulting Issuer Shares. As such, the Transaction will result in a reverse takeover of the Steep Hill by the shareholders of Good Purpose upon completion of the Transaction, and the Resulting Issuer’s primary business will be the business of Good Purpose. In connection with the Transaction, the Steep Hill intends to: (i) change its name to “Good Purpose Investments Inc.” or such other name as the Steep Hill and Good Purpose may mutually agree; (ii) change its stock exchange ticker symbol to a symbol to be determined between the parties and acceptable to the CSE; (iii) consolidate its issued and outstanding common shares on the basis of one post consolidation common shares for every three pre-consolidation common shares of the Steep Hill; and (iv) reconstitute its board of directors and management team. Completion of the Transaction is subject to a number of terms and conditions customary for transactions of this nature, including, among other things, Good Purpose having completed the Good Purpose Financing receipt of all necessary shareholder and regulatory approvals contemplated in the Amalgamation Agreement, the execution of related transaction documents, and listing approval of the CSE. In addition, the Transaction must be approved by not less than 66?% of the votes cast at a meeting of shareholders of Good Purpose. The Company will also seek approval of the Transaction, the Name Change and the Consolidation at a meeting of the Steep Hill's shareholders. Certain securities issued in connection with the Transaction will be subject to escrow requirements of the CSE, mutually agreed upon escrow conditions, and hold periods as required by the CSE and applicable securities laws.공시 • Jul 04Lir Life Sciences Inc. cancelled the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction.Lir Life Sciences Inc. entered into a share purchase agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 8.2 million in a reverse merger transaction on February 12, 2025. As part of the consideration, 136,054,422 common shares of Steep Hill issued at the price of CAD 0.147. Lir will be required to complete an equity financing for proceeds of at least CAD 1,000,000 concurrently with the closing of the Acquisition, and the Company’s shares will be consolidated on a 3-for-1 basis immediately following completion of the Acquisition and Concurrent Financing. Concurrently with the completion of the Acquisition, all current Directors of the Company, except for Mr. Sameet Kanade, will resign and be replaced by nominees of LIR. The transaction is subject to the approval of target's shareholders, regulatory approvals and the consummation of concurrent financing. Lir Life Sciences Inc. cancelled the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction on July 3, 2025.공시 • Apr 02Steep Hill Inc., Annual General Meeting, May 15, 2025Steep Hill Inc., Annual General Meeting, May 15, 2025.공시 • Mar 05Steep Hill Inc., Annual General Meeting, Apr 07, 2025Steep Hill Inc., Annual General Meeting, Apr 07, 2025.공시 • Feb 14Lir Life Sciences Inc. entered into a share purchase agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 8.2 million in a reverse merger transaction.Lir Life Sciences Inc. entered into a share purchase agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 8.2 million in a reverse merger transaction on February 12, 2025. As part of the consideration, 136,054,422 common shares of Steep Hill issued at the price of CAD 0.147. Lir will be required to complete an equity financing for proceeds of at least CAD 1,000,000 concurrently with the closing of the Acquisition, and the Company’s shares will be consolidated on a 3-for-1 basis immediately following completion of the Acquisition and Concurrent Financing. Concurrently with the completion of the Acquisition, all current Directors of the Company, except for Mr. Sameet Kanade, will resign and be replaced by nominees of LIR. The transaction is subject to the approval of target's shareholders, regulatory approvals and the consummation of concurrent financing.Board Change • Jul 26High number of new and inexperienced directorsThere are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. 2 experienced directors. No highly experienced directors. Independent Director Ian Morton is the most experienced director on the board, commencing their role in 2021. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.New Risk • Jun 04New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$1.3m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$1.3m free cash flow). Share price has been highly volatile over the past 3 months (52% average weekly change). Earnings have declined by 24% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (€326.3k market cap, or US$354.5k).공시 • Apr 24Steep Hill Inc., Annual General Meeting, Jul 26, 2024Steep Hill Inc., Annual General Meeting, Jul 26, 2024.New Risk • Apr 17New major risk - Revenue sizeThe company makes less than US$1m in revenue. This is considered a major risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (67% average weekly change). Earnings have declined by 36% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (€275.4k market cap, or US$293.9k).Reported Earnings • Nov 29Third quarter 2023 earnings released: EPS: CA$0 (vs CA$0 in 3Q 2022)Third quarter 2023 results: EPS: CA$0 (in line with 3Q 2022). Net loss: CA$68.4k (loss narrowed 29% from 3Q 2022).Reported Earnings • Sep 01First half 2023 earnings released: CA$0.003 loss per share (vs CA$0.008 loss in 1H 2022)First half 2023 results: CA$0.003 loss per share (improved from CA$0.008 loss in 1H 2022). Net loss: CA$379.0k (loss narrowed 78% from 1H 2022).공시 • Jul 06Steep Hill Inc. Announces Demise of Director, David WaltersThe Board of Directors and management of Steep Hill Inc. announce that Director, David Walters, has passed away. David joined the board at the time of the go-public transaction of Canbud Distribution Corp., (now called Steep Hill Inc) and during his time with the company provided oversight as Audit Committee chair. On behalf of the Board of Directors and team, company extend the deepest condolences to David's family and to all those who came to know him as a colleague and as a friend.공시 • Jun 04Steep Hill Inc. Announces Chief Financial Officer ChangeSteep Hill Inc. announced that Raj Ravindran has resigned as the company's Chief Financial Officer to pursue other endeavors. Raj was one of the co-founders of Canbud Distribution Corp., the entity that culminated into Steep Hill following the acquisitions made in 2021 and 2022. The board announced the appointment of Ms. Patricia Militello as Interim CFO. Since fourth quarter of 2021, Ms. Militello has been instrumental in leading the finance and accounting team as an external consultant. Ms. Militello is expected to lend her expertise as Steep Hill continues on the path of restructuring and exploring strategic alternatives.공시 • May 19Steep Hill Inc., Annual General Meeting, Jul 28, 2023Steep Hill Inc., Annual General Meeting, Jul 28, 2023.Board Change • Dec 02High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 3 experienced directors. No highly experienced directors. Founder, CFO & Director Raj Ravindran is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Board Change • Apr 27High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 2 experienced directors. No highly experienced directors. Founder, CFO & Director Raj Ravindran is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Board Change • Mar 07High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 2 experienced directors. No highly experienced directors. Founder, CFO & Director Raj Ravindran is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.주주 수익률CD0DE PharmaceuticalsDE 시장7D0%6.1%3.2%1Y-14.7%27.3%2.5%전체 주주 수익률 보기수익률 대 산업: CD0은 지난 1년 동안 27.3%의 수익을 기록한 German Pharmaceuticals 산업보다 저조한 성과를 냈습니다.수익률 대 시장: CD0은 지난 1년 동안 2.5%를 기록한 German 시장보다 저조한 성과를 냈습니다.주가 변동성Is CD0's price volatile compared to industry and market?CD0 volatilityCD0 Average Weekly Movementn/aPharmaceuticals Industry Average Movement6.4%Market Average Movement6.1%10% most volatile stocks in DE Market13.3%10% least volatile stocks in DE Market2.7%안정적인 주가: CD0의 주가는 지난 3개월 동안 German 시장보다 변동성이 컸습니다.시간에 따른 변동성: Insufficient data to determine CD0의 변동성 변화를 판단할 수 없습니다.회사 소개설립직원 수CEO웹사이트2008n/aSameet Kanadewww.steephill.com는 별다른 사업을 운영하고 있지 않습니다. 이전에는 캐나다에서 대마초 과학 회사로 운영되었습니다. 이 회사는 이전에는 캔버드 디스트리뷰션 주식회사로 알려졌으며, 2022년 2월에 스팁 힐 주식회사로 사명을 변경했습니다.더 보기Steep Hill Inc. 기초 지표 요약Steep Hill의 순이익과 매출은 시가총액과 어떻게 비교됩니까?CD0 기초 통계시가총액€550.79k순이익 (TTM)-€138.46k매출 (TTM)n/a0.0x주가매출비율(P/S)-4.0x주가수익비율(P/E)CD0는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표CD0 손익계산서 (TTM)매출CA$0매출원가CA$0총이익CA$0기타 비용CA$223.70k순이익-CA$223.70k최근 보고된 실적Sep 30, 2025다음 실적 발표일해당 없음주당순이익(EPS)-0.014총이익률0.00%순이익률0.00%부채/자본 비율0%CD0의 장기 실적은 어땠습니까?과거 실적 및 비교 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/02/10 06:43종가2025/11/13 00:00수익2025/09/30연간 수익2024/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Steep Hill Inc.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • May 16Good Purpose Investments Inc. completed the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction.Good Purpose Investments Inc. entered into an agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 1.8 million in a reverse merger transaction on November 12, 2025. Good Purpose shareholders will exchange all of the common shares of Good Purpose for post-Consolidation common shares of the Resulting Issuer based on an exchange ratio equal to one Resulting Issuer Shares for each one Good Purpose Share to a maximum of 62 million Resulting Issuer Shares. As of December 19, 2025, the parties entered into an amending agreement such that Good Purpose shareholders will exchange all of the common shares of Good Purpose for post-consolidation common shares of the Resulting Issuer, based on an exchange ratio equal to one Resulting Issuer Shares for each one Good Purpose Share to a maximum of 30,818,614 Resulting Issuer Shares. As such, the Transaction will result in a reverse takeover of the Steep Hill by the shareholders of Good Purpose upon completion of the Transaction, and the Resulting Issuer’s primary business will be the business of Good Purpose. In connection with the Transaction, the Steep Hill intends to: (i) change its name to “Good Purpose Investments Inc.” or such other name as the Steep Hill and Good Purpose may mutually agree; (ii) change its stock exchange ticker symbol to a symbol to be determined between the parties and acceptable to the CSE; (iii) consolidate its issued and outstanding common shares on the basis of one post consolidation common shares for every three pre-consolidation common shares of the Steep Hill; and (iv) reconstitute its board of directors and management team. Completion of the Transaction is subject to a number of terms and conditions customary for transactions of this nature, including, among other things, Good Purpose having completed the Good Purpose Financing receipt of all necessary shareholder and regulatory approvals contemplated in the Amalgamation Agreement, the execution of related transaction documents, and listing approval of the CSE. In addition, the Transaction must be approved by not less than 66% of the votes cast at a meeting of shareholders of Good Purpose. The Company will also seek approval of the Transaction, the Name Change and the Consolidation at a meeting of the Steep Hill's shareholders. Certain securities issued in connection with the Transaction will be subject to escrow requirements of the CSE, mutually agreed upon escrow conditions, and hold periods as required by the CSE and applicable securities laws. Steep Hill Inc. board recommend the transaction. The special meeting of shareholders of Steep Hill will be held to approve the transaction on March 26, 2026. As of March 26, 2026, the parties extended the outside date for completion of the transaction to May 7, 2026. Endeavor Trust Corporation acted as transfer agent for Steep Hill Inc. Good Purpose Investments Inc. completed the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction on May 14, 2026. Upon completion of the Transaction, 7.36% of the Common Shares being held by shareholders of Steep Hill Inc. and 92.64% of the Common Shares being held by GPI shareholders. Steep Hill Inc. changed its name to Good Purpose Investments Inc. The Common Shares are expected to commence trading on the CSE under the new name and the new ticker symbol “GPIN” as of market open on May 19, 2026. Concurrently with Closing, the board of directors of Steep Hill Inc. was reconstituted to consist of Monique Maissan, Max Whiffin, Hani Zabaneh and Sameet Kanade. George Tsogas has been appointed Chief Executive Officer, Melissa Kinnoch has been appointed Chief Financial Officer and Corporate Secretary, Monique Maissan has been appointed Chief Development Officer and Max Whiffin has been appointed Vice President, Corporate Development.
공시 • Nov 14Good Purpose Investments Inc. entered into an agreement to acquire Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction.Good Purpose Investments Inc. entered into an agreement to acquire Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction on November 12, 2025. Good Purpose shareholders will exchange all of the common shares of Good Purpose for post-Consolidation common shares of the Resulting Issuer based on an exchange ratio equal to one Resulting Issuer Shares for each one Good Purpose Share to a maximum of 62 million Resulting Issuer Shares. As such, the Transaction will result in a reverse takeover of the Steep Hill by the shareholders of Good Purpose upon completion of the Transaction, and the Resulting Issuer’s primary business will be the business of Good Purpose. In connection with the Transaction, the Steep Hill intends to: (i) change its name to “Good Purpose Investments Inc.” or such other name as the Steep Hill and Good Purpose may mutually agree; (ii) change its stock exchange ticker symbol to a symbol to be determined between the parties and acceptable to the CSE; (iii) consolidate its issued and outstanding common shares on the basis of one post consolidation common shares for every three pre-consolidation common shares of the Steep Hill; and (iv) reconstitute its board of directors and management team. Completion of the Transaction is subject to a number of terms and conditions customary for transactions of this nature, including, among other things, Good Purpose having completed the Good Purpose Financing receipt of all necessary shareholder and regulatory approvals contemplated in the Amalgamation Agreement, the execution of related transaction documents, and listing approval of the CSE. In addition, the Transaction must be approved by not less than 66?% of the votes cast at a meeting of shareholders of Good Purpose. The Company will also seek approval of the Transaction, the Name Change and the Consolidation at a meeting of the Steep Hill's shareholders. Certain securities issued in connection with the Transaction will be subject to escrow requirements of the CSE, mutually agreed upon escrow conditions, and hold periods as required by the CSE and applicable securities laws.
공시 • Jul 04Lir Life Sciences Inc. cancelled the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction.Lir Life Sciences Inc. entered into a share purchase agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 8.2 million in a reverse merger transaction on February 12, 2025. As part of the consideration, 136,054,422 common shares of Steep Hill issued at the price of CAD 0.147. Lir will be required to complete an equity financing for proceeds of at least CAD 1,000,000 concurrently with the closing of the Acquisition, and the Company’s shares will be consolidated on a 3-for-1 basis immediately following completion of the Acquisition and Concurrent Financing. Concurrently with the completion of the Acquisition, all current Directors of the Company, except for Mr. Sameet Kanade, will resign and be replaced by nominees of LIR. The transaction is subject to the approval of target's shareholders, regulatory approvals and the consummation of concurrent financing. Lir Life Sciences Inc. cancelled the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction on July 3, 2025.
공시 • Apr 02Steep Hill Inc., Annual General Meeting, May 15, 2025Steep Hill Inc., Annual General Meeting, May 15, 2025.
공시 • Mar 05Steep Hill Inc., Annual General Meeting, Apr 07, 2025Steep Hill Inc., Annual General Meeting, Apr 07, 2025.
공시 • Feb 14Lir Life Sciences Inc. entered into a share purchase agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 8.2 million in a reverse merger transaction.Lir Life Sciences Inc. entered into a share purchase agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 8.2 million in a reverse merger transaction on February 12, 2025. As part of the consideration, 136,054,422 common shares of Steep Hill issued at the price of CAD 0.147. Lir will be required to complete an equity financing for proceeds of at least CAD 1,000,000 concurrently with the closing of the Acquisition, and the Company’s shares will be consolidated on a 3-for-1 basis immediately following completion of the Acquisition and Concurrent Financing. Concurrently with the completion of the Acquisition, all current Directors of the Company, except for Mr. Sameet Kanade, will resign and be replaced by nominees of LIR. The transaction is subject to the approval of target's shareholders, regulatory approvals and the consummation of concurrent financing.
공시 • May 16Good Purpose Investments Inc. completed the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction.Good Purpose Investments Inc. entered into an agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 1.8 million in a reverse merger transaction on November 12, 2025. Good Purpose shareholders will exchange all of the common shares of Good Purpose for post-Consolidation common shares of the Resulting Issuer based on an exchange ratio equal to one Resulting Issuer Shares for each one Good Purpose Share to a maximum of 62 million Resulting Issuer Shares. As of December 19, 2025, the parties entered into an amending agreement such that Good Purpose shareholders will exchange all of the common shares of Good Purpose for post-consolidation common shares of the Resulting Issuer, based on an exchange ratio equal to one Resulting Issuer Shares for each one Good Purpose Share to a maximum of 30,818,614 Resulting Issuer Shares. As such, the Transaction will result in a reverse takeover of the Steep Hill by the shareholders of Good Purpose upon completion of the Transaction, and the Resulting Issuer’s primary business will be the business of Good Purpose. In connection with the Transaction, the Steep Hill intends to: (i) change its name to “Good Purpose Investments Inc.” or such other name as the Steep Hill and Good Purpose may mutually agree; (ii) change its stock exchange ticker symbol to a symbol to be determined between the parties and acceptable to the CSE; (iii) consolidate its issued and outstanding common shares on the basis of one post consolidation common shares for every three pre-consolidation common shares of the Steep Hill; and (iv) reconstitute its board of directors and management team. Completion of the Transaction is subject to a number of terms and conditions customary for transactions of this nature, including, among other things, Good Purpose having completed the Good Purpose Financing receipt of all necessary shareholder and regulatory approvals contemplated in the Amalgamation Agreement, the execution of related transaction documents, and listing approval of the CSE. In addition, the Transaction must be approved by not less than 66% of the votes cast at a meeting of shareholders of Good Purpose. The Company will also seek approval of the Transaction, the Name Change and the Consolidation at a meeting of the Steep Hill's shareholders. Certain securities issued in connection with the Transaction will be subject to escrow requirements of the CSE, mutually agreed upon escrow conditions, and hold periods as required by the CSE and applicable securities laws. Steep Hill Inc. board recommend the transaction. The special meeting of shareholders of Steep Hill will be held to approve the transaction on March 26, 2026. As of March 26, 2026, the parties extended the outside date for completion of the transaction to May 7, 2026. Endeavor Trust Corporation acted as transfer agent for Steep Hill Inc. Good Purpose Investments Inc. completed the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction on May 14, 2026. Upon completion of the Transaction, 7.36% of the Common Shares being held by shareholders of Steep Hill Inc. and 92.64% of the Common Shares being held by GPI shareholders. Steep Hill Inc. changed its name to Good Purpose Investments Inc. The Common Shares are expected to commence trading on the CSE under the new name and the new ticker symbol “GPIN” as of market open on May 19, 2026. Concurrently with Closing, the board of directors of Steep Hill Inc. was reconstituted to consist of Monique Maissan, Max Whiffin, Hani Zabaneh and Sameet Kanade. George Tsogas has been appointed Chief Executive Officer, Melissa Kinnoch has been appointed Chief Financial Officer and Corporate Secretary, Monique Maissan has been appointed Chief Development Officer and Max Whiffin has been appointed Vice President, Corporate Development.
공시 • Nov 14Good Purpose Investments Inc. entered into an agreement to acquire Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction.Good Purpose Investments Inc. entered into an agreement to acquire Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction on November 12, 2025. Good Purpose shareholders will exchange all of the common shares of Good Purpose for post-Consolidation common shares of the Resulting Issuer based on an exchange ratio equal to one Resulting Issuer Shares for each one Good Purpose Share to a maximum of 62 million Resulting Issuer Shares. As such, the Transaction will result in a reverse takeover of the Steep Hill by the shareholders of Good Purpose upon completion of the Transaction, and the Resulting Issuer’s primary business will be the business of Good Purpose. In connection with the Transaction, the Steep Hill intends to: (i) change its name to “Good Purpose Investments Inc.” or such other name as the Steep Hill and Good Purpose may mutually agree; (ii) change its stock exchange ticker symbol to a symbol to be determined between the parties and acceptable to the CSE; (iii) consolidate its issued and outstanding common shares on the basis of one post consolidation common shares for every three pre-consolidation common shares of the Steep Hill; and (iv) reconstitute its board of directors and management team. Completion of the Transaction is subject to a number of terms and conditions customary for transactions of this nature, including, among other things, Good Purpose having completed the Good Purpose Financing receipt of all necessary shareholder and regulatory approvals contemplated in the Amalgamation Agreement, the execution of related transaction documents, and listing approval of the CSE. In addition, the Transaction must be approved by not less than 66?% of the votes cast at a meeting of shareholders of Good Purpose. The Company will also seek approval of the Transaction, the Name Change and the Consolidation at a meeting of the Steep Hill's shareholders. Certain securities issued in connection with the Transaction will be subject to escrow requirements of the CSE, mutually agreed upon escrow conditions, and hold periods as required by the CSE and applicable securities laws.
공시 • Jul 04Lir Life Sciences Inc. cancelled the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction.Lir Life Sciences Inc. entered into a share purchase agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 8.2 million in a reverse merger transaction on February 12, 2025. As part of the consideration, 136,054,422 common shares of Steep Hill issued at the price of CAD 0.147. Lir will be required to complete an equity financing for proceeds of at least CAD 1,000,000 concurrently with the closing of the Acquisition, and the Company’s shares will be consolidated on a 3-for-1 basis immediately following completion of the Acquisition and Concurrent Financing. Concurrently with the completion of the Acquisition, all current Directors of the Company, except for Mr. Sameet Kanade, will resign and be replaced by nominees of LIR. The transaction is subject to the approval of target's shareholders, regulatory approvals and the consummation of concurrent financing. Lir Life Sciences Inc. cancelled the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction on July 3, 2025.
공시 • Apr 02Steep Hill Inc., Annual General Meeting, May 15, 2025Steep Hill Inc., Annual General Meeting, May 15, 2025.
공시 • Mar 05Steep Hill Inc., Annual General Meeting, Apr 07, 2025Steep Hill Inc., Annual General Meeting, Apr 07, 2025.
공시 • Feb 14Lir Life Sciences Inc. entered into a share purchase agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 8.2 million in a reverse merger transaction.Lir Life Sciences Inc. entered into a share purchase agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 8.2 million in a reverse merger transaction on February 12, 2025. As part of the consideration, 136,054,422 common shares of Steep Hill issued at the price of CAD 0.147. Lir will be required to complete an equity financing for proceeds of at least CAD 1,000,000 concurrently with the closing of the Acquisition, and the Company’s shares will be consolidated on a 3-for-1 basis immediately following completion of the Acquisition and Concurrent Financing. Concurrently with the completion of the Acquisition, all current Directors of the Company, except for Mr. Sameet Kanade, will resign and be replaced by nominees of LIR. The transaction is subject to the approval of target's shareholders, regulatory approvals and the consummation of concurrent financing.
Board Change • Jul 26High number of new and inexperienced directorsThere are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. 2 experienced directors. No highly experienced directors. Independent Director Ian Morton is the most experienced director on the board, commencing their role in 2021. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.
New Risk • Jun 04New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$1.3m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$1.3m free cash flow). Share price has been highly volatile over the past 3 months (52% average weekly change). Earnings have declined by 24% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (€326.3k market cap, or US$354.5k).
공시 • Apr 24Steep Hill Inc., Annual General Meeting, Jul 26, 2024Steep Hill Inc., Annual General Meeting, Jul 26, 2024.
New Risk • Apr 17New major risk - Revenue sizeThe company makes less than US$1m in revenue. This is considered a major risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (67% average weekly change). Earnings have declined by 36% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (€275.4k market cap, or US$293.9k).
Reported Earnings • Nov 29Third quarter 2023 earnings released: EPS: CA$0 (vs CA$0 in 3Q 2022)Third quarter 2023 results: EPS: CA$0 (in line with 3Q 2022). Net loss: CA$68.4k (loss narrowed 29% from 3Q 2022).
Reported Earnings • Sep 01First half 2023 earnings released: CA$0.003 loss per share (vs CA$0.008 loss in 1H 2022)First half 2023 results: CA$0.003 loss per share (improved from CA$0.008 loss in 1H 2022). Net loss: CA$379.0k (loss narrowed 78% from 1H 2022).
공시 • Jul 06Steep Hill Inc. Announces Demise of Director, David WaltersThe Board of Directors and management of Steep Hill Inc. announce that Director, David Walters, has passed away. David joined the board at the time of the go-public transaction of Canbud Distribution Corp., (now called Steep Hill Inc) and during his time with the company provided oversight as Audit Committee chair. On behalf of the Board of Directors and team, company extend the deepest condolences to David's family and to all those who came to know him as a colleague and as a friend.
공시 • Jun 04Steep Hill Inc. Announces Chief Financial Officer ChangeSteep Hill Inc. announced that Raj Ravindran has resigned as the company's Chief Financial Officer to pursue other endeavors. Raj was one of the co-founders of Canbud Distribution Corp., the entity that culminated into Steep Hill following the acquisitions made in 2021 and 2022. The board announced the appointment of Ms. Patricia Militello as Interim CFO. Since fourth quarter of 2021, Ms. Militello has been instrumental in leading the finance and accounting team as an external consultant. Ms. Militello is expected to lend her expertise as Steep Hill continues on the path of restructuring and exploring strategic alternatives.
공시 • May 19Steep Hill Inc., Annual General Meeting, Jul 28, 2023Steep Hill Inc., Annual General Meeting, Jul 28, 2023.
Board Change • Dec 02High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 3 experienced directors. No highly experienced directors. Founder, CFO & Director Raj Ravindran is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Board Change • Apr 27High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 2 experienced directors. No highly experienced directors. Founder, CFO & Director Raj Ravindran is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Board Change • Mar 07High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 2 experienced directors. No highly experienced directors. Founder, CFO & Director Raj Ravindran is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
